Užsispyręs subtilus Nesąžiningumas vas narasimhan Meldimas Ūkvedys Saulės nudegimas
Vasant Narasimhan: Biography of Vasant Narasimhan CEO of Novartis
Novartis CEO Vas Narasimhan on M&A and Taking Earlier Risks on New Technology
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
It was never my plan to be the boss of a huge company' - BBC News
CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a mistake he's determined to overcome | Fierce Pharma
Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash | Barron's
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Watch Novartis CEO Vasant Narasimhan on Growth Prospects, Coronavirus Pandemic, Covid-19 Vaccines: Video - Bloomberg
Novartis CEO Vasant Narasimhan on China's coronavirus outbreak
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
Managing My Energy, Not My Time
It was never my plan to be the boss of a huge company' - BBC News
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company - YouTube
Indian-origin CEOs take pride in identity': Novartis's Vas Narasimhan
CEO's letter - Novartis Annual Review 2019
Vas Narasimhan on LinkedIn: Five Things That Changed My Perspective in 2020 | 243 comments
Novartis CEO in the hotseat after revelation that his company submitted falsified data to the FDA - The Boston Globe
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Meet Vasant Narasimhan, the CEO of Novartis who earns Rs 20 lakh per day? Know about his lifestyle, education and family | The Financial Express
Vas Narasimhan: the American trying to reshape Novartis | Financial Times
Novartis CEO Sees 'Better Place' With Covid by Year-End - Bloomberg
Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are working to help more people get access to the medicines they need #AccessinAction | Facebook
Srishti Gupta with Vas Narasimhan
Novartis CEO Vas Narasimhan On The Price Of Gene Therapies: 'It's A Challenge We Have To Solve'
Novartis faces a new crisis. For CEO Vas Narasimhan, this time is different